EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Postoperative Pain in Patients Receiving Ketoprofen After Total Hip Arthroplasty: The Role of Pharmacogenetics

Natalia P. Denisenko, Anastasia A. Anderzhanova, Dmitriy A. Lysov, Dmitriy I. Gordienko, Yulia A. Meleshkina, Mikhail I. Tsarev, Maria V. Lukina, Svetlana N. Tuchkova, Ivan V. Sychev, Anna S. Zhiryakova, Sergey I. Markov, Karin B. Mirzaev und 1 weitere

Future Pharmacology · 03.05.2026 · 6 (2) · 28

DOI: 10.3390/futurepharmacol6020028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Future Pharmacology, online erschienen am 03.05.2026. Verfasst von Natalia P. Denisenko und 12 weiteren Autor:innen. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Ministry of Science and Higher Education of the Russian Federation.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Ketoprofen is one of the most commonly prescribed NSAIDs; however, its pharmacogenetics remains poorly understood. The objective was to evaluate the influence of patients’ pharmacogenetic profiles on the effectiveness of ketoprofen for postoperative pain management after total hip arthroplasty, including postoperative analgesia (pain levels, opioid consumption) and the incidence of adverse reactions during hospitalization and up to 12 months post-surgery.

Methods

The study included 53 patients (31 (58.49%) women, median age 66.0 [60.0–74.0] years) undergoing total hip arthroplasty. Genotyping was performed using real-time PCR to analyze 18 single-nucleotide polymorphisms (SNPs) across the following genes: CYP2C9 (rs1799853, rs1057910), CYP2C8 (rs10509681, rs11572080), CYP3A4 (rs35599367), CYP3A5 (rs776746), UGT2B7 (rs73823859, rs7439366, rs7668282), ABCB1 (rs1045642, rs4148738, rs2032582, rs1128503), PTGS1 (rs10306135, rs12353214), PTGS2 (rs20417), C3orf20 (rs12496846), and ZNF493-ZNF429 (rs2562456).

Results

We did not find significant associations between patients’ genotypes and pain levels or postoperative opioid analgesic consumption or adverse reactions when ketoprofen was used for pain management in patients undergoing total hip arthroplasty.

Conclusions

Routine pharmacogenetic testing for ketoprofen is not supported by our findings.

Förderung

  • the Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Denisenko, N. P., Anderzhanova, A. A., Lysov, D. A., Gordienko, D. I., Meleshkina, Y. A., Tsarev, M. I., Lukina, M. V., Tuchkova, S. N., Sychev, I. V., Zhiryakova, A. S., Markov, S. I., Mirzaev, K. B., & Sychev, D. A. (2026). Postoperative Pain in Patients Receiving Ketoprofen After Total Hip Arthroplasty: The Role of Pharmacogenetics. Future Pharmacology, 6(2), 28. https://doi.org/10.3390/futurepharmacol6020028

Vancouver

Denisenko NP, Anderzhanova AA, Lysov DA, Gordienko DI, Meleshkina YA, Tsarev MI, et al. Postoperative Pain in Patients Receiving Ketoprofen After Total Hip Arthroplasty: The Role of Pharmacogenetics. Future Pharmacology. 2026;6(2):28. doi:10.3390/futurepharmacol6020028

BibTeX
@article{Denisenko2026,
  author = {Denisenko, Natalia P. and Anderzhanova, Anastasia A. and Lysov, Dmitriy A. and Gordienko, Dmitriy I. and Meleshkina, Yulia A. and Tsarev, Mikhail I. and Lukina, Maria V. and Tuchkova, Svetlana N. and Sychev, Ivan V. and Zhiryakova, Anna S. and Markov, Sergey I. and Mirzaev, Karin B. and Sychev, Dmitry A.},
  title = {Postoperative Pain in Patients Receiving Ketoprofen After Total Hip Arthroplasty: The Role of Pharmacogenetics},
  journal = {Future Pharmacology},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {28},
  doi = {10.3390/futurepharmacol6020028}
}
Kostenlos starten →